VERAPAMIL PHARMACODYNAMICS AFTER INTRAVENOUS AND ORAL DOSING - THEORETIC CONSIDERATION

被引：6

作者：

COLBURN, WA

BRAZZELL, RK

HOLAZO, AA

机构：

[1] WARNER LAMBERT PARKE DAVIS,DEPT DRUG METAB,ANN ARBOR,MI 48105

[2] ALCON LABS INC,FT WORTH,TX 76101

[3] HOFFMANN LA ROCHE INC,NUTLEY,NJ 07110

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1986年 / 26卷 / 01期

关键词：

D O I：

10.1002/j.1552-4604.1986.tb02906.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：71 / 73

页数：3

共 7 条

[1] SIMULTANEOUS PHARMACOKINETIC AND PHARMACODYNAMIC MODELING [J].

COLBURN, WA .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1981, 9 (03) :367-388

[2] EFFECTS OF VERAPAMIL ON P-R-INTERVALS IN RELATION TO VERAPAMIL PLASMA-LEVELS FOLLOWING SINGLE IV AND ORAL-ADMINISTRATION AND DURING CHRONIC TREATMENT [J].

EICHELBAUM, M ;

BIRKEL, P ;

GRUBE, E ;

GUTGEMANN, U ;

SOMOGYI, A .

KLINISCHE WOCHENSCHRIFT, 1980, 58 (18) :919-925

[3] ACCUMULATION IN THE PERIPHERAL COMPARTMENT OF A LINEAR 2-COMPARTMENT OPEN MODEL [J].

GONDA, I ;

HARPUR, ES .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1980, 8 (01) :99-104

[4] UNDERSTANDING THE DOSE-EFFECT RELATIONSHIP - CLINICAL-APPLICATION OF PHARMACOKINETIC-PHARMACODYNAMIC MODELS [J].

HOLFORD, NHG ;

SHEINER, LB .

CLINICAL PHARMACOKINETICS, 1981, 6 (06) :429-453

[5] THE PHARMACOLOGY OF VERAPAMIL .4. KINETIC AND DYNAMIC EFFECTS AFTER SINGLE INTRAVENOUS AND ORAL DOSES [J].

MCALLISTER, RG ;

KIRSTEN, EB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (04) :418-426

[6]

METZLER CM, 1974, BIOMETRICS, V30, P562

[7] COMPARISON OF INTRAVENOUS AND ORAL VERAPAMIL DOSING [J].

REITER, MJ ;

SHAND, DG ;

PRITCHETT, ELC .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (06) :711-720

← 1 →